Acadia Pharmaceuticals Inc. (ACAD) vs Parabilis Medicines, Inc. (PBLS)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and Parabilis Medicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acadia Pharmaceuticals Inc. logo
ACAD
Acadia Pharmaceuticals Inc.
$3.39B
$19.79HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Parabilis Medicines, Inc. logo
PBLS
Parabilis Medicines, Inc.
$3.33B
$28.60HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT

Total return — ACAD vs PBLS

growth of $100 · dividends reinvested · last 1y
ACAD -6.2% (-6.2%/yr)PBLS +47.7% (+47.7%/yr)PBLS compounded faster over this window
100150200Start $100$94$148
ACAD PBLS

ACAD vs PBLS: by the numbers

  • •ACAD is the larger company ($3.39B vs $3.33B market cap).
  • •ACAD is profitable (33.42% net margin) while PBLS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricACADPBLS
P/E ratio8.91N/A
Forward P/E32.12N/A
P/S ratio2.98N/A
P/B ratio2.593.18
EV / EBITDA31.27N/A
FCF yield5.15%N/A

Profitability

MetricACADPBLS
Gross margin91.13%0.00%
Operating margin7.59%0.00%
Net margin33.42%0.00%
ROE29.12%N/A
ROIC6.25%-409.85%

Growth (annualized)

MetricACADPBLS
Revenue CAGR (5Y)19.70%N/A
Total return CAGR (5Y)3.52%N/A

Frequently asked

Is ACAD or PBLS more profitable?
ACAD runs the higher net margin — ACAD at 33.42% versus PBLS at 0.00%.

Go deeper

Full ACAD analysisFull PBLS analysisInteractive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratioAcadia Pharmaceuticals ROEParabilis Medicines ROEAcadia Pharmaceuticals operating marginParabilis Medicines operating marginAcadia Pharmaceuticals revenue growthParabilis Medicines revenue growthAcadia Pharmaceuticals free cash flowParabilis Medicines free cash flow

Acadia Pharmaceuticals & Parabilis Medicines appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.